Skip to main content
Premium Trial:

Request an Annual Quote

Pharmacopeia Completes Spin-Off of PDD; to be Renamed Accelrys Soon

NEW YORK, May 3 (GenomeWeb News) - Pharmacopeia has completed the spin-off of Pharmacopeia Drug Discovery, the company said today.

 

As of today, Pharmacopeia and PDD will trade as separate companies on Nasdaq under the ticker symbols "ACCL" and "PCOP", respectively. Pharmacopeia plans to change its name to Accelrys upon approval by its stockholders later this month.

 

Pharmacopeia will be headquartered in San Diego, while PDD will stay in Princeton.